Product Description

Onax 2mg Extended-Release Tablets have been shown to cause injury to the human fetus. If you plan on turning into pregnant, consult with your doctor the benefits and risks of exploitation anti-anxiety drug Extended-Release Tablets throughout maternity. anti-anxiety drug Extended-Release Tablets are excreted in breast milk. do not breast-feed whereas taking anti-anxiety drug Extended-Release Tablets.
Onax 2mg maternity Warnings
Onax 2mg has been assigned to maternity category D by the government agency. associate increased risk of inherent malformations in humans has been suggested with the use of various benzodiazepines, tho little studies havent concerned antianxiety drug. Withdrawal symptoms are painted in neonates whose mothers took anti-anxiety drug throughout maternity. There arent any controlled information in human maternity. antianxiety drug use is taken into consideration contraindicated throughout maternity.